Tipranavir

In the US, Tipranavir (tipranavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection.

US matches:

• Tipranavir


• Tipranavir Solution

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE09

CAS registry number (Chemical Abstracts Service)

0174484-41-4

Chemical Formula

C31-H33-F3-N2-O5-S

Molecular Weight

602

Therapeutic Category

Antiviral agent, HIV protease inhibitor, nonpeptidic

Chemical Names

2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluormethyl)-

2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluormethyl)-, (R-(R*,R*))-

3'-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl]propyl]-5-(trifluoromethyl)-2-pyridinesulfonanilide (WHO)

N-(3-{(1R)-1-[(6R)-4-Hydroxy-2-oxo-6-(2-phenethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluormethyl)-2-pyridin-2-sulfonamid (IUPAC)

Foreign Names

• Tipranavirum (Latin)
• Tipranavir (German)
• Tipranavir (French)
• Tipranavir (Spanish)

Generic Names

• Tipranavir (OS: BAN)
• PNU-140690 (IS: PharmaciaUpjoh)
• U-140690 (IS: PharmaciaUpjoh)

Brand Names

• Aptivus
  Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Canada; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Spain; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, United States; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Luxembourg



• Atripla
  Boehringer Ingelheim, Ireland

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.